-
A Marijuana REIT Is About To Hit The Market
Monday, November 7, 2016 - 9:18am | 349Read More...Investors have been looking to profit from marijuana stocks for the past few years as the industry is gaining from more lax restrictions and an increase in public support. In fact, several states will vote in the upcoming election to legalize or regulate marijuana sales to the public....
-
3 Weed Stocks To Put On Your Radar
Friday, October 28, 2016 - 9:51am | 556Read More...Marijuana stocks have been on the rise ahead of legalization initiatives on ballots in nine states in November. However, a number of stocks have not participated in the rally. With nearly every marijuana stock trading on the oft-dangerous over-the-counter markets, it can be difficult to...
-
Marijuana Expert: 'We're In The Middle Of The Second Boom'
Friday, October 28, 2016 - 7:31am | 543Read More...Alan Brochstein, founder of the 420 Investor, stopped by PreMarket Prep on Thursday to talk about the state of the marijuana industry as several states ramp up to vote on legalizing the drug next month. November will be a critical turning point for the drug, as supporters have fought for...
-
Exclusive: GW Pharmaceuticals Talks Epidiolex, Raising Capital & Growing Its Sales Force
Tuesday, September 27, 2016 - 11:15am | 573Read More...GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a developer of cannabinoid prescription medicines, saw its stock surge Monday after the company reported positive results from a clinical study. Wall Street took notice with some firms reaffirming their bullish stance on the stock and placing price...
-
Why This Epidiolex Trial Was Different
Monday, September 26, 2016 - 9:21am | 337Read More...Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a developer of cannabinoid prescription medicines, spiked by more than 10 percent Monday morning following the company's announcement that Epidiolex achieved a primary endpoint in a Phase 3 clinical study. Epidiolex, GW Pharma's lead...
-
GW Pharmaceuticals Takeover Talk 'Seems A Bit Premature'
Thursday, September 8, 2016 - 9:23am | 317Read More...Shares of GW Pharmaceuticals PLC - ADR (NASDAQ: GWPH) soared Wednesday from around $83 per share to close at $104.03 after Reuters reported the company is in talks with an investment banks to consider strategic alternatives. GW Pharmaceuticals is a developer of marijuana-based epilepsy...
-
Why You Should Be Excited About GW Pharma
Wednesday, April 20, 2016 - 5:07pm | 340Read More...GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) could become a one-of-its-kind company if the FDA approves the company's cannabis-based drug for child epilepsy as a late-stage study showed positive results. The company also commenced a Phase 3 clinical trial of Epidiolex as an adjunctive therapy...
-
Happy 420! Here's How To Invest In Legal Marijuana
Wednesday, April 20, 2016 - 4:20pm | 502Read More...Happy 420! Even though marijuana is not legal at the federal level, those interested in taking part in Wacky Weed Day's festivities can do so through investing. On Wednesday, Benzinga's PreMarket Prep hosts Joel Elconin and Dennis Dick were joined by Alan Brochstein, the "420...
-
Want To Invest In Marijuana? Look To Canada
Wednesday, April 20, 2016 - 2:26pm | 493Read More...April 20 of each year marks a celebration for marijuana enthusiasts, despite the herb still being illegal in most of the country. For investors, what this means is until marijuana becomes legalized at the federal level, you'll be hard pressed to find many pot stocks trading in New York....
-
GW Pharma Shares Double Following Positive Epidiolex Trial
Monday, March 14, 2016 - 10:14am | 324Read More...Shares of GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) are up nearly 120 percent in early Monday trading after the company announced positive Phase III data on Epidiolex. The study found that the drug significantly reduced seizures in children suffering from Dravet Syndrome, a condition for which...
-
#PreMarket Prep Guest List For The Week Of January 26, 2015
Monday, January 26, 2015 - 9:11am | 1129Read More...Fund managers, market technicians and veteran traders will all be guests on this week’s #PreMarket Prep broadcast, sponsored by Marketfy. Be sure to tune in at 8:00 a.m. EST Monday-Friday here to tune in to the exciting show. Monday, January 26, 8:35 a.m. Anne-Marie Baiynd (@AnneMarieTrades...
-
GW Pharmaceuticals Opens Lowers, Has Huge Recovery
Thursday, January 8, 2015 - 2:24pm | 281Read More...Marketfy Mavens Alan Brochstein and Rod David commented on GW Pharmaceuticals PLC (ADR) (NASDAQ: GWPH) following the company’s disappointing drug trial news. Brochstein noted that "the market is initially focused upon the setback," however, "the company also announced...
-
Rambo's Reads For January 4, 2015
Sunday, January 4, 2015 - 12:46pm | 209Read More...My new dog, Rambo, humors me when I talk about the markets. Every Sunday, Rambo and I will share what we've been reading. Here's our picks for the first Sunday of 2015: Ben Casselman explains why the conventional wisdom on oil is always wrong. Josh Brown has fun with Wall Street...
-
59 Financial Experts Just Revealed What 2015 Could Bring
Tuesday, December 30, 2014 - 5:55pm | 5314Read More...Benzinga recently asked more than 50 experts what they'll be watching in the New Year. All responses in italics are direct quotes and shortened for this article. The full list of predictions can be downloaded for free here. So...what's your best trading and investing tip going into...
-
12 Money Myths Just Debunked By Experts
Friday, November 14, 2014 - 11:36am | 1599Read More...Wall Street isn't the most transparent place in the world. Day traders, casual investors and even those looking to diversify their retirement portfolios are subject to a number of money myths lurking beneath the market's surface. Benzinga interviewed 12 financial experts to discover...













